FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 57 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $832,581 | -17.6% | 110,863 | -3.2% | 0.00% | – |
| Q2 2023 | $1,010,885 | -10.6% | 114,483 | -37.1% | 0.00% | – |
| Q1 2021 | $1,131,000 | -25.6% | 182,107 | -10.7% | 0.00% | – |
| Q4 2020 | $1,520,000 | +21.4% | 203,999 | -1.3% | 0.00% | – |
| Q3 2020 | $1,252,000 | -30.9% | 206,634 | -4.7% | 0.00% | – |
| Q2 2020 | $1,811,000 | +366.8% | 216,860 | +123.6% | 0.00% | – |
| Q2 2019 | $388,000 | -21.6% | 96,972 | -5.0% | 0.00% | – |
| Q1 2019 | $495,000 | -23.8% | 102,077 | +0.2% | 0.00% | – |
| Q4 2018 | $650,000 | -22.3% | 101,857 | -0.2% | 0.00% | – |
| Q3 2018 | $837,000 | -20.9% | 102,085 | +0.7% | 0.00% | – |
| Q2 2018 | $1,058,000 | – | 101,332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |